Skip to main navigation Skip to search Skip to main content

Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: Therapy with sequential 1-β -D-arabinofuranosylcytosine, mitoxantrone, and bevacizumab

Research output: Contribution to journal › Article › peer-review

154   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: Therapy with sequential 1-β -D-arabinofuranosylcytosine, mitoxantrone, and bevacizumab'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology